Fifth Third Bancorp increased its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 138.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 353,969 shares of the semiconductor company's stock after buying an additional 205,354 shares during the period. Fifth Third Bancorp's holdings in Lam Research were worth $75,629,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of the stock. Valued Wealth Advisors LLC grew its position in shares of Lam Research by 7.9% in the first quarter. Valued Wealth Advisors LLC now owns 589 shares of the semiconductor company's stock valued at $126,000 after purchasing an additional 43 shares during the last quarter. Greenup Street Wealth Management LLC increased its stake in shares of Lam Research by 1.8% during the first quarter. Greenup Street Wealth Management LLC now owns 2,433 shares of the semiconductor company's stock worth $520,000 after purchasing an additional 44 shares during the period. Triumph Capital Management lifted its holdings in Lam Research by 22.5% during the 4th quarter. Triumph Capital Management now owns 245 shares of the semiconductor company's stock worth $42,000 after purchasing an additional 45 shares during the last quarter. Traphagen Investment Advisors LLC boosted its stake in Lam Research by 2.4% in the 4th quarter. Traphagen Investment Advisors LLC now owns 1,963 shares of the semiconductor company's stock valued at $336,000 after purchasing an additional 46 shares during the period. Finally, Sachetta LLC boosted its stake in Lam Research by 13.3% in the 1st quarter. Sachetta LLC now owns 393 shares of the semiconductor company's stock valued at $84,000 after purchasing an additional 46 shares during the period. 84.61% of the stock is owned by institutional investors.
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Mizuho raised its price target on Lam Research to $400 from $380 and kept an outperform rating, adding to the bullish analyst momentum around the stock.
- Positive Sentiment: Stifel Nicolaus boosted its target to $425 from $325 and reiterated a buy rating, citing above-consensus estimates and suggesting further upside for LRCX.
- Positive Sentiment: Needham also increased its target to $390 from $300 and maintained a buy rating, reinforcing the view that Lam Research is well positioned to benefit from AI-driven chip demand.
- Positive Sentiment: Additional coverage highlighted Lam Research as a beneficiary of broader AI infrastructure spending and possible easing of China-related chip restrictions, which could improve sentiment across semiconductor equipment names. Does AI Rebound and China Chip Access Shift Change The Bull Case For Lam Research (LRCX)?
- Neutral Sentiment: Lam Research announced that it will host its June quarter financial conference call and webcast on July 29, giving investors a near-term catalyst to watch.
- Neutral Sentiment: Short-interest data showed no meaningful change, with reported short interest at zero shares, so it does not appear to be a factor driving the move.
Analysts Set New Price Targets
Several research firms have weighed in on LRCX. Stifel Nicolaus increased their price objective on Lam Research from $325.00 to $425.00 and gave the stock a "buy" rating in a research report on Friday. Zacks Research cut shares of Lam Research from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 6th. Berenberg Bank upped their price target on shares of Lam Research from $265.00 to $335.00 and gave the company a "buy" rating in a research note on Thursday, April 23rd. B. Riley Financial raised their price target on shares of Lam Research from $350.00 to $375.00 and gave the stock a "buy" rating in a research report on Tuesday, May 12th. Finally, Barclays reiterated an "overweight" rating and issued a $335.00 price objective (up from $275.00) on shares of Lam Research in a research note on Thursday, June 11th. Twenty-eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $350.81.
Read Our Latest Stock Report on LRCX
Insider Buying and Selling at Lam Research
In other news, SVP Neil J. Fernandes sold 18,170 shares of the business's stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $255.14, for a total value of $4,635,893.80. Following the completion of the transaction, the senior vice president directly owned 66,129 shares in the company, valued at approximately $16,872,153.06. The trade was a 21.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company's stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director directly owned 199,205 shares of the company's stock, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 86,339 shares of company stock valued at $27,680,267 in the last ninety days. 0.31% of the stock is currently owned by company insiders.
Lam Research Stock Performance
NASDAQ:LRCX opened at $350.33 on Monday. The stock has a fifty day moving average price of $334.89 and a 200-day moving average price of $264.23. The company has a market cap of $438.11 billion, a price-to-earnings ratio of 66.10, a PEG ratio of 2.07 and a beta of 1.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54. Lam Research Corporation has a fifty-two week low of $90.93 and a fifty-two week high of $438.50.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to analysts' expectations of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.Lam Research's revenue was up 23.8% on a year-over-year basis. During the same quarter last year, the business earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, equities analysts anticipate that Lam Research Corporation will post 5.68 EPS for the current fiscal year.
Lam Research Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Wednesday, June 17th. Lam Research's dividend payout ratio (DPR) is currently 19.62%.
Lam Research Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.